|
Please mark
and submit your answers on the Post-Test /
Evaluation Form . Do NOT mark your answers on this page and please
do not submit your answers marked on this page to PIM.
- Which of the
following statements about chronic kidney disease (CKD) is true?
a. Twenty million Americans have CKD.
b. There is a link between CKD, anemia of CKD, and heart disease.
c. Patients with CKD have a 10- to 1,000-fold higher risk of death from heart disease.
d. All of the above
- A 15 mmHg increase
in systolic blood pressure is associated with a 37% increase in the
risk of heart disease. The same risk is imparted by a __ decrease in
hemoglobin.
a. 0.5 g/dL
b. 0.8 g/dL
c. 1.5 g/dL
d. 1.8 g/dl
- According
to Obrador et al, the average hematocrit among patients in the US who
start dialysis is
__ a. 35.1%
b. 33.5%
c. 31.2%
d. 27.9%
- The majority
of patients receive an erythropoietic agent before starting dialysis.
a. True
b. False
- In the US,
the primary cause of end-stage renal disease (ESRD) is ___ .
a. hypertension
b. focal segmental glomerulosclerosis
c. congenital abnormalities
d. diabetes mellitus
- Diabetes is
the primary cause of ESRD among which of the following groups?
a. Whites
b. African-Americans and Hispanics
c. Native American and Asians
d. All of the above e. b and c only
- The longer
half-life of darbepoetin alfa allows a longer dosing interval that,
in turn, allows for __ .
a. increased capacity for providers to treat more patients
b. fewer patient visits that translates to increased patient convenience and compliance
c. cost effectiveness due to increased efficiency in the clinic
d. all of the above
- One way to
improve consistency of treatment of CKD patients is to implement a protocol
for anemia and iron management.
a. True
b. False